Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, D.
Right arrow Articles by Lopez, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, D.
Right arrow Articles by Lopez, C. D.
[Cancer Research 66, 3485-3494, April 1, 2006]
© 2006 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

The p53 Pathway Promotes Efficient Mitochondrial DNA Base Excision Repair in Colorectal Cancer Cells

Dexi Chen1, Zhiyong Yu1,2, Zhiyi Zhu1 and Charles D. Lopez1

1 Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon and 2 Shandong Tumor Hospital and Institute, Jinan, China

Requests for reprints: Charles D. Lopez, Department of Medicine, Division of Hematology and Medical Oncology, Mail Code L586B, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97201-3098. Phone: 503-494-8321; Fax: 503-418-0844; E-mail: lopezc{at}ohsu.edu.

The tumor suppressor p53 plays a central role in the DNA damage response. p53 enhances base excision repair (BER), in part, through direct interaction with the repair complex. Mitochondrial DNA (mtDNA) is repaired by a mtBER pathway. Many colorectal cancers harbor mtDNA mutations that are associated with poor prognosis. In addition to modulating the apoptotic response, mitochondria-localized p53 also stimulates mtBER. However, the mechanisms by which p53 enhances colorectal cancer mtBER after stress remain unclear. To explore this, we used colorectal cancer cells isogenic for p53 (HCT116p53+/+ and HCT116p53–/–). p53+/+ cells more efficiently repaired H2O2 damaged DNA in vivo as measured by semiquantitative mtDNA displacement loop PCR. Mitochondrial extracts from p53+/+ cells more efficiently stimulated 32P-dCTP incorporation into a uracil-oligonucleotide. Recombinant p53 complemented p53–/– mitochondrial extract repair of uracil or 8-oxo-G–containing oligonucleotides. As a measure of DNA glycosylase activity, p53+/+ mitochondrial extracts more efficiently incised uracil or 8-oxo-G oligonucleotides, although recombinant p53 could not stimulate oligonucleotide incision. p53 did not influence mitochondrial apurinic/apyrimidinic endonuclease activity measured by incision of a tetrahydrofuran-oligonucleotide. p53+/+ mitochondrial extracts had higher DNA polymerase-{gamma} activity measured by 32P-dCTP incorporation into a single-nucleotide gap oligonucleotide, and recombinant p53 complemented p53–/– mitochondrial extract DNA polymerase-{gamma} activity. mtDNA ligase activity was not affected by p53 status. p53 protein was detected in an inner mitochondrial membrane subfraction containing components of the mtBER complex. Our data suggest that an intact p53 pathway stimulates specific mtBER steps and provides mechanistic insight into the development of mtDNA mutations in colorectal cancer. (Cancer Res 2006; 66(7): 3485-94)




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
G. S. Shadel
Expression and Maintenance of Mitochondrial DNA: New Insights into Human Disease Pathology
Am. J. Pathol., June 1, 2008; 172(6): 1445 - 1456.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Tembe and B. R. Henderson
BARD1 Translocation to Mitochondria Correlates with Bax Oligomerization, Loss of Mitochondrial Membrane Potential, and Apoptosis
J. Biol. Chem., July 13, 2007; 282(28): 20513 - 20522.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
R. Nithipongvanitch, W. Ittarat, J. M. Velez, R. Zhao, D. K. St. Clair, and T. D. Oberley
Evidence for p53 as Guardian of the Cardiomyocyte Mitochondrial Genome Following Acute Adriamycin Treatment
J. Histochem. Cytochem., June 1, 2007; 55(6): 629 - 639.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Zhou, S. Kachhap, W. Sun, G. Wu, A. Chuang, L. Poeta, L. Grumbine, S. K. Mithani, A. Chatterjee, W. Koch, et al.
Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck
PNAS, May 1, 2007; 104(18): 7540 - 7545.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.